Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol

PURPOSE: In the absence of head-to-head clinical trials comparing the once-daily, long-acting beta2-agonists olodaterol and indacaterol for the treatment of chronic obstructive pulmonary disease (COPD), an indirect treatment comparison by systematic review and synthesis of the available clinical evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Roskell, Neil S, Anzueto, Antonio, Hamilton, Alan, Disse, Bernd, Becker, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124050/
https://www.ncbi.nlm.nih.gov/pubmed/25114521
http://dx.doi.org/10.2147/COPD.S59673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124050/
https://www.ncbi.nlm.nih.gov/pubmed/25114521
http://dx.doi.org/10.2147/COPD.S59673

Ejemplares similares